Impact BioMedical Inc.
IBO
$0.55
-$0.03-5.64%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 48.59% | 52.09% | -3,893.22% | -806.10% | -438.96% |
| Total Depreciation and Amortization | 20,314.29% | 16,271.43% | 14,266.67% | 60.00% | 16.67% |
| Total Amortization of Deferred Charges | -99.73% | -100.09% | -75.22% | 0.81% | 0.09% |
| Total Other Non-Cash Items | -56.37% | -61.57% | 918.77% | 7,761.73% | 6,706.35% |
| Change in Net Operating Assets | 213.43% | 198.68% | -200.28% | -174.48% | -167.98% |
| Cash from Operations | 45.25% | 33.78% | -29.29% | -70.62% | -31.69% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -66.67% | 50.00% | -33.33% | 0.00% | 50.00% |
| Cash from Investing | -66.67% | 50.00% | -33.33% | 100.00% | 127.27% |
| Total Debt Issued | 3.90% | -83.63% | -69.49% | -86.95% | -72.50% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -91.46% | -102.25% | -93.35% | 102.29% | 87.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -198.63% | -199.90% | -207.66% | 62,300.00% | 131,500.00% |